EUVIMEDOpdag EUVIMED
Open access · CC BY 4.0

Super7 passaging method to improve Chinese hamster ovary cell fed‐batch performance

Matthew J Moran, Jin Chen, James M Piret, R Robert Balcarcel

Biotechnology and Bioengineering · 2024

DOI: 10.1002/bit.28723 ↗

At a glance

Journal article in Biotechnology and Bioengineering, 2024. Written by Matthew J Moran and 3 co-authors. Institution: Bayer U.S. LLC, Pharmaceuticals, BD Cell Culture Development, Berkeley, California, USA. Major MEDLINE topics: Cricetulus, Batch Cell Culture Techniques, Antibodies, Monoclonal. Cited 1 times so far (Crossref); 18 references. The full text is freely available (open access, CC BY 4.0). Funded by: Bayer HealthCare.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Chinese hamster ovary (CHO) cells are widely used to manufacture biopharmaceuticals, most of all monoclonal antibodies (mAbs). Some CHO cell lines exhibit production instability, where the productivity of the cells decreases as a function of time in culture. To counter this, we designed a passaging strategy that, rather than maximizing the time spent in log‐growth phase, mimics the first 7 days of a fed‐batch production process. Cultures passaged using this method had lower net growth rates and were more oxidative throughout 6 weeks of passaging. Fed‐batch cultures inoculated by cells passaged using this method had increased net growth rates, oxidative metabolism, and volumetric productivity compared to cells passaged using a conventional strategy. Cells from unstable cell lines passaged by this new method produced 80%–160% more mAbs per unit volume than cells passaged by a conventional method. This new method, named Super7, provides the ability to mitigate the impact of production instability in CHO‐K1 cell lines without a need for further cell line creation, genetic engineering, or medium development.

Subjects

MeSH terms (MEDLINE)

CricetulusBatch Cell Culture TechniquesAntibodies, MonoclonalCHO CellsAnimalsCricetinaeCell Culture TechniquesBioreactorsRecombinant ProteinsCell Proliferation

Author keywords

Chinese hamster ovary (CHO) cell lineculture passagingglycolysisoxidative metabolismproduction instabilityrecombinant protein

Substances

Antibodies, MonoclonalRecombinant Proteins

Authors and institutions

  • Bayer U.S. LLC, Pharmaceuticals, BD Cell Culture Development, Berkeley, California, USA.
  • Department of Chemical & Biological Engineering, Michael Smith Laboratories, School of Biomedical Engineering, University of British Columbia, Vancouver, British Columbia, Canada.

Funding

  • Bayer HealthCare

Cite

APA

Moran, M. J., Chen, J., Piret, J. M., & Balcarcel, R. R. (2024). Super7 passaging method to improve Chinese hamster ovary cell fed‐batch performance. Biotechnology and Bioengineering. https://doi.org/10.1002/bit.28723

Vancouver

Moran MJ, Chen J, Piret JM, Balcarcel RR. Super7 passaging method to improve Chinese hamster ovary cell fed‐batch performance. Biotechnology and Bioengineering. 2024. doi:10.1002/bit.28723

BibTeX
@article{Moran2024,
  author = {Moran, Matthew J and Chen, Jin and Piret, James M and Balcarcel, R Robert},
  title = {Super7 passaging method to improve Chinese hamster ovary cell fed‐batch performance},
  journal = {Biotechnology and Bioengineering},
  year = {2024},
  doi = {10.1002/bit.28723}
}
Start for free →